Consistently, METTL14 mRNA was highly expressed in BM-MNCs of MDS cases with blasts ≥ 5%, and was upregulated as the IPSS-R risk increased (Fig. 1H, I; Supplementary Fig. 1). The gene discussed is METTL14; the disease is myelodysplastic syndrome.